Zimmer Biomet
1,008 hedge funds and large institutions have $20.2B invested in Zimmer Biomet in 2024 Q2 according to their latest regulatory filings, with 95 funds opening new positions, 309 increasing their positions, 401 reducing their positions, and 85 closing their positions.
12% more first-time investments, than exits
New positions opened: 95 | Existing positions closed: 85
0.12% more ownership
Funds ownership: 90.49% → 90.61% (+0.12%)
0% less funds holding
Funds holding: 1,013 → 1,008 (-5)
11% less funds holding in top 10
Funds holding in top 10: 9 → 8 (-1)
17% less capital invested
Capital invested by funds: $24.5B → $20.2B (-$4.25B)
23% less repeat investments, than reductions
Existing positions increased: 309 | Existing positions reduced: 401
38% less call options, than puts
Call options by funds: $45.4M | Put options by funds: $73.6M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$220M |
| 2 |
American Century Companies
Kansas City,
Missouri
|
+$85.1M |
| 3 |
MF
Magnetar Financial
Evanston,
Illinois
|
+$57.2M |
| 4 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$46.9M |
| 5 |
D.E. Shaw & Co
New York
|
+$44.3M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$160M |
| 2 |
Invesco
Atlanta,
Georgia
|
-$92.2M |
| 3 |
Capital Research Global Investors
Los Angeles,
California
|
-$79.6M |
| 4 |
Neuberger Berman Group
New York
|
-$75.5M |
| 5 |
BlackRock
New York
|
-$51.7M |
ZBH Hedge Fund Activity: Q2 2024 in Review
1,008 of the 6,935 institutional investors tracked by Wall St. Rank reported a position in Zimmer Biomet (ZBH) for Q2 2024, worth a combined $20.2B — down 17% from $24.5B a quarter earlier.
Buyers outnumbered sellers: 95 funds opened new ZBH positions and 85 closed out — a net gain of 10 holders — while 309 added to existing stakes and 401 trimmed.
The largest buyer was T. Rowe Price Associates, adding an estimated $220M. The largest seller was Millennium Management, cutting an estimated $160M.
- 1,008 institutional investors held Zimmer Biomet (ZBH) as of Q2 2024, down from 1,013 in Q1 2024.
- Funds reported $20.2B of Zimmer Biomet stock for Q2 2024, down 17% quarter-over-quarter.
- 95 funds opened new Zimmer Biomet positions in Q2 2024 and 85 closed out, a net change of +10 holders.
- The largest Zimmer Biomet buyer in Q2 2024 was T. Rowe Price Associates, an estimated $220M added.
- The largest Zimmer Biomet seller in Q2 2024 was Millennium Management, an estimated $160M sold.
Based on aggregated 13F filings for Q2 2024.